Vaccines Market Research Reports & Industry Analysis
Because of the large number of deadly diseases that have been eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements of the 20th century. Key issues in the global vaccine market today include unequal access to vaccines, supply chain disruptions, the use of vaccines to prevent pandemics and address bioterrorism, technological innovations, and vaccine hesitancy. Learn more about this critical field with the comprehensive selection of vaccine market research reports available on MarketResearch.com.
New Vaccines Market Data and Insights
- Find data on vaccine market size segmented by region, technology, distribution channel, type, route of administration, and disease.
- Gain a deep understanding of vaccine industry dynamics, market structure, growth outlook, and competitive landscape.
- Learn about influential government initiatives and new vaccination technologies that have highly promising results.
Your Source for Expert Data and Analysis
MarketResearch.com is a trusted research partner, backed by over two decades of experience. Our clients include top investment banks, management consulting firms, and leading multinational companies within the Fortune 500. Our team of research specialists is dedicated to guiding you at every step, ensuring you have the resources and insights you need to answer your toughest research questions. Browse our full list of vaccines industry reports today.
Vaccines Industry Research & Market Reports
-
France Vaccines Market Overview, 2028
... reducing illness, disability, and mortality caused by a wide range of pathogens. Vaccines work by stimulating the immune system to recognize and combat specific viruses or bacteria, creating immunity without causing the disease itself. This ... Read More
-
South Korea Vaccines Market Overview, 2028
... strong foundation in pharmaceutical research and development, South Korea has emerged as a key player in the global vaccine market. This thriving industry is characterised by its dedication to disease prevention, cutting-edge research initiatives, and ... Read More
-
Brazil Vaccines Market Overview, 2028
... significantly to the prevention of vaccine-preventable diseases. Brazil has legislation that mandates certain vaccines for specific age groups. For example, vaccines against diseases like measles, mumps, rubella, diphtheria, tetanus, and pertussis (DPT) are required for ... Read More
-
India Vaccines Market Overview, 2028
... 2012 India's pharmaceutical industry market value has been growing significantly. The vaccine storage temperature and cold chain logistics play a large role in how India is able to safely deliver life-saving vaccines all across the ... Read More
-
Single-Use Bioprocessing Probes and Sensors Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... forecast period. COVID-19 had significantly benefited the market in terms of adoption and revenue growth. The pandemic has accelerated the application of single-use solutions, including sensors, to meet the technology demand for therapeutics and vaccine ... Read More
-
Global Influenza Vaccine Market: Analysis by Valency (Quadrivalent & Trivalent), By Vaccine Type (Inactivated And Live Attenuated), By Technology (Egg-based & Cell-based), By Age Group (Adult & Pediatric), By Route Of Administration (Injection & Nasal Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028
... Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028 The influenza vaccine, often referred to as the flu ... Read More
-
MENA Biologics & Biosimilars Market, By Product Type (Influenza Vaccines, Factor VIII ( Xyntha, Octanate, Kovaltry, Advate, Koate, Adynovate, Kogenate, Hemlibra, Elocta, Recombinate, Feiba, Immunate, Alphanate, Novoeight), Erythropoietin (Epoetin Alfa (Procrit, Epogen), Darbepoietin Alfa (Aranesp), Epoetin Alfa-epbx (Retacrit)), Aflibercept (EYLEA), and Ziv-Aflibercept (ZALTRAP))), By Therapeutic Application (Hemophilia, Age-related Macular Degeneration, Kidney Diseases, Influenza, and Others), By Geography (Gulf and Egypt)
... Epoetin Alfa-epbx (Retacrit)), Aflibercept (EYLEA), and Ziv-Aflibercept (ZALTRAP))), By Therapeutic Application (Hemophilia, Age-related Macular Degeneration, Kidney Diseases, Influenza, and Others), By Geography (Gulf and Egypt) MENA Biologics & Biosimilars Market, By Product Type (Influenza Vaccines, ... Read More
-
U.S. Pharma E-commerce Market Size, Share & Trends Analysis Report By Product Type (Vaccines, Specialty Care), By Therapeutic Area (Diabetes, Immune-system Diseases), By Type, By Market Type, By Platform, And Segment Forecasts, 2023 - 2030
... U.S. Pharma E-commerce Market Growth & Trends The U.S. pharma E-commerce market size is anticipated to reach USD 50.77 billion by 2030, growing at a CAGR of 19.8% from 2023 to 2030, according to a ... Read More
-
Global Meningococcal Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Meningococcal Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Meningococcal Vaccines. The report also introduces players in the industry ... Read More
-
Malaria Treatment Global Market Report 2023 Including: 1) By Treatment: Prescription Medications; Vaccines; Diagnostic Tests 2) By Route of Administration: Oral; Parenteral; Intravenous 3) By Distribution Channel: Direct Tender; Hospital Pharmacies; Retail Pharmacies; Online Pharmacies 4) By End User: Hospitals; Specialty Clinics; Homecarers Covering: Pfizer Inc.; Merck & Co.; Johnson & Johnson; Roche Holding AG; Bayer AG
... User: Hospitals; Specialty Clinics; HomecarersCovering: Pfizer Inc.; Merck & Co.; Johnson & Johnson; Roche Holding AG; Bayer AG Malaria Treatment Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Oral Typhoid Vaccine Market
... Residents of Endemic Areas, Healthcare Workers), By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Typhoid fever, an infectious disease caused by the bacterium Salmonella typhi, remains a significant global health ... Read More
-
Travel Vaccines Global Market Report 2023 Including: 1) By Disease: Hepatitis A; Diphtheria, Pertussis, And Tetanus (DPT); Yellow Fever; Typhoid; Hepatitis B; Measles And Mumps; Rabies; Meningococcal; 2) By Composition: Mono Vaccines; Combination Vaccines 3) By Booking Channel: Online Booking; In-Person Booking 4) By Application: Domestic Travel; Outbound Travel Covering: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA
... Channel: Online Booking; In-Person Booking4) By Application: Domestic Travel; Outbound TravelCovering: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA Travel Vaccines Global Market Report 2023 from The Business Research Company ... Read More
-
Neoantigen Targeted Therapies Global Market Report 2023 Including: 1) By Type: Monotherapy; Combination Therapy 2) By Immunotherapy Type: DNA Or RNA-Based Vaccines; Protein-Based Vaccines; Dendritic Cell Vaccines; TIL-Based Therapies 3) By Target Disease Indication: Colorectal Cancer; Renal Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer 4) By Route of Administration: Intradermal; Intravenous; Subcutaneous 5) By Application: Medical Research Institution; Hospital; and Clinic Covering: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company
... Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer4) By Route of Administration: Intradermal; Intravenous; Subcutaneous5) By Application: Medical Research Institution; Hospital; and ClinicCovering: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers ... Read More
-
Influenza Vaccines Global Market Report 2023 Including: 1) By Vaccine Type: Inactivated; Live Attenuated 2) By Valency: Quadrivalent; Trivalent 3) By Route Of Administration: Injection; Nasal Spray 4) By Age Group: Pediatric; Adult 5) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply Covering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC.
... Pharmacies; Government And Institutional SupplyCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC. Influenza Vaccines Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Anti-infective Vaccines Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increased Occurrence of New and Re-emerging Infectious Illnesses Driving Market ... Read More
-
Fill Finish Manufacturing Global Market Report 2023 Including: 1) By Product: Consumables; Instruments 2) By Modality: Recombinant Proteins; Monoclonal Antibodies; Vaccines; Cell Therapies; Viral Gene Therapies; Non-Viral Gene Therapies 3) By End-User: Contract Manufacturing Organizations; Biopharmaceutical Companiess Covering: Johnson And Johnson; AbbVie Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson And Company; Baxter International Inc.
... Johnson And Johnson; AbbVie Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson And Company; Baxter International Inc. Fill Finish Manufacturing Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with ... Read More
-
RNA Therapeutics and RNA Vaccines Market, 2023-2035 (Forecasted Estimates)
... and is expected to grow at compounded annual growth rate (CAGR) of 50% during the forecast period (2026-2035). In the past few years, RNA based therapeutics have emerged as one of the key therapeutic modalities ... Read More
-
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) - Global Forecast to 2028
... projected to grow from USD 13.7 billion in 2023 to USD 18.0 billion by 2028 at a CAGR of 5.6%. The key factors driving the overall market growth include an increase in the number of ... Read More
-
Biotechnology Contract Manufacturing Market by Service (Manufacturing, Fill Finish, Packaging), Type (Drug Substance, Drug Product), Scale, Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecasts to 2028
... manufacturing market is estimated to reach USD 24.8 billion by 2028 from USD 16.6 billion in 2023, at a CAGR of 8.3% during the forecast period of 2023 to 2028. The growth of this market ... Read More
-
Global Toxoid Vaccine Market - 2023-2030
... period 2023-2030. Toxoid vaccines use toxoids (as antigens) to induce an immune response in protecting against diseases caused by toxins secreted by specific bacteria. Compared to other vaccines, toxoid vaccines are more stable and less ... Read More
-
Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing), Therapeutic Area (Oncology, Cardiology, Neurology), and Application (Vaccine, mAbs, CGT) - Global Forecast to 2028
... clinical trials market is projected to reach USD 73.2 billion by 2028 from USD 48.2 billion in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The growth of this ... Read More
-
North America Travel Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028. Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They ... Read More
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), Route of administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Type ( Human vaccine , Veterinary vaccine) - Global Forecast to 2028
... size is projected to reach USD 1.2 billion by 2028 from USD 0.8 billion in 2023, at a CAGR of 6.9% during the forecast period. Factors such as as the rising prevalence of infectious diseases, ... Read More
-
Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.61% during 2023-2028. Cancer is a malignant tumor caused by the uncontrollable growth of abnormal cells in the body. It can be treated ... Read More
-
Microcarrier Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... is a help matrix, which lets in the increase of adherent cells in bioreactors. In the large-scale business production of biologics and vaccines, microcarriers are employed to grow virus-generating or protein-producing adherent cellular populations. As ... Read More
Research Assistance
